Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance: Microbiology Testing with the aim of Directed Antimicrobial Therapy for Community-Adquired Pneumonia

This is a multi-center clinical trial sponsored by the NIH. Dr. Victor Yu from the University of Pittsburgh is the Principal Investigator.

The University of Louisville is one of the six centers participating in the trial. This proposal is under contract negotiation with the NIH.

Dr. Ramirez is the Principal Investigator for the University of Louisville site. The proposed budget for the University of Louisville is in the amount of $2,424,015 for the 5-year duration of the study.